Whoops.
The novel antithrombotic vorapaxar causes intracranial hemorrhage in patients with a history of stroke, Merck announced, explaining why stroke survivors were dropped from trials of the experimental drug.

Whoops.
The novel antithrombotic vorapaxar causes intracranial hemorrhage in patients with a history of stroke, Merck announced, explaining why stroke survivors were dropped from trials of the experimental drug.

Medical News: FDA Approves New Antidepressant – in Product Alert, Prescriptions from MedPage Today
Vilazodone (Viibryd) has been approved for treatment of major depression, the FDA announced.
Plasma and dietary magnesium and risk of sudden cardiac death in women — Am J Clin Nutr
If the observed association is causal…
In an e-mail, an Aurora spokesman said Sagar’s firing was not related to her presentation.
“Dr. Sagar’s contract was terminated for a number of reasons, none related to her study. This was in no way a retaliatory action. As a matter of fact, the study supported our quality improvement initiatives and has resulted in heightened standards in the echo lab.”
Calculated Risk: Summary for Week ending January 8th
I sincerely hope my readers continue on to read the source articles of my posts. I always credit my sources and thank them all for providing content.
I do claim credit for the persnickety comments.

In Women, Diabetes Plus Depression a Deadly Combo
Women who had diabetes had about a 35 percent increased risk of dying, and those with depression had about a 44 percent increased risk, compared with women with neither condition, the researchers calculated.
Those with both conditions had about twice the risk of dying, the study authors found.

Why Is The US Taxpayer Subsidizing Facebook – And The Next Bubble? « The Baseline Scenario
If you don’t care about Facebook you will after reading this excellent article.

You must be logged in to post a comment.